[1] |
TAN Yong, LIU Hui, WU Li-ming, LIU Wen-ying, OU-YANG Zai-xing, HU Le-sheng, SONG Hao, HUANG Cong-yun, WU Qing-song.
The relationship between preoperative serum hepatitis B virus DNA load and postoperative liver function in patients with hepatocellular carcinoma resection
[J]. Lingnan Modern Clinics In Surgery, 2024, 24(04): 209-214.
|
[2] |
ZHENG Biao, CHEN Xu, QIAN Junlin, XU Baoshi, ZHEN Chaohui, LIANG Rui.
Expression of RAD54B in liver hepatocellular carcinoma and its influence on clinical prognosis
[J]. Lingnan Modern Clinics In Surgery, 2024, 24(04): 225-230.
|
[3] |
ZHU Pei-feng, WANG Yong.
Recurrence of primary thyroid paraganglioma with trachea invasion: a case report and literature reviews
[J]. Lingnan Modern Clinics In Surgery, 2024, 24(02): 127-130.
|
[4] |
PENG Lin-hui, CHEN Tao, XU Yun-xiu-xiu, WANG Jie, CHEN Jie, LI Yong, HUANG Pin-bo, ZHONG Guo-ping, CHEN Qian, YE Cong-ting, CHEN Ya-jin.
mFOLFOX7 venous chemotherapy plus camrelizumab and apatinib for hepatocellular carcinoma in CNLC stage Ⅲ (VIC-TRIPLET): a prospective study
[J]. Lingnan Modern Clinics In Surgery, 2024, 24(01): 1-6.
|
[5] |
LUO Wan-rong, ZHANG Wen-yue, LUO Bao-ming.
Construction and validation of a prognostic risk model for hepatocellular carcinoma based on angiogenesis-related lncRNAs
[J]. Lingnan Modern Clinics In Surgery, 2024, 24(01): 7-13.
|
[6] |
LIN Kun-peng, BA Ming-chen, TANG Yun-qiang, WANG Jia-kang, LIN Xiao-chun.
Correlation analysis of FAM72 gene family in prognosis and immune infiltration of hepatocellular carcinoma
[J]. Lingnan Modern Clinics In Surgery, 2024, 24(01): 14-25.
|
[7] |
DONG Yi-ming, SHI Chuan-ping, LIAO Jian-you.
Effects of knockdown BRIX1 on proliferation, migration and invasion of triple negative breast cancer cells
[J]. Lingnan Modern Clinics In Surgery, 2024, 24(01): 42-48.
|
[8] |
HUANG Zhi-feng, JIAO Yuan-jun, XU Zhe, LIU Ji-kui, HUANG Dong, OU Xi, LIU Xiao-ping.
FOXP3 promotes cell migration via EMT in hepatocellular cancer
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(06): 449-454.
|
[9] |
HUANG Gui-zhong, LIN Qiao-hong, YIN Peng-fei, ZHANG Jian-long.
Constructing and validating an online predictive model of severe postoperative complication for hepatocellular carcinoma
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(04): 289-293.
|
[10] |
LUO Xuan, LONG Yin, HUANG Zi-qi, HE Xiao-dong, HUANG Jue, LIAO Jian-guo, ZHANG Lei.
Real-world analysis of mFOLFOX systemic chemotherapy combined with immunotherapy and targeted therapy for unresectable hepatocellular carcinoma
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(04): 294-301.
|
[11] |
QIAN Jun-lin, TANG Hong-tao, LIN Wei, HU Ze-min.
Research progress of hepatic arterial infusion chemotherapy with FOLFOX regimen
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(04): 347-352.
|
[12] |
HUANG Rui-qin, HE Kun, QIAN Jun-lin, LUO Qi-jie.
Analysis of risk factors affecting the postoperative prognosis of patients with hepatocellular carcinoma:a single-center analysis
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(03): 205-214.
|
[13] |
WU Wei-zi, ZHANG Guan-lan, TANG Yu-xing, ZHENG Qing, CHEN Yu, CHEN Ji-tian, ZHAN Yan-ting, MO Wei-jia.
Clinical value of up-regulated expression of ANAPC5 mRNA in hepatocellular carinnoma and analysis of related pathways
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(03): 230-237.
|
[14] |
LIU Li-qing, ZHANG Li, JIN Yan, XU Jing.
Research progress on risk factors of postoperative recurrence of liver cancer
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(03): 269-276.
|
[15] |
CHEN Xi, CHEN Jie, CHEN Tao, CHEN Ya-jin.
Interpreting the updates of the 2023 Version 1 NCCN hepatocellular carcinoma clinical practice guidelines
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(02): 95-99.
|